“…miRNAs represent endogenous non-protein-coding small noncoding RNAs, 18-25 nucleotides in length, that have been implicated in a wide array of tumor cell physiological processes including cell proliferation, invasion, apoptosis, and self-renewal by interacting with their specific target genes (Wang et al, Abbreviations: 3 UTR, 3 untranslated region; AGAP2-AS1, AGAP2 antisense RNA 1; Ago2, Argonaute 2; ANOVA, analysis of variance; BCA, bicinchoninic acid; BPH, benign prostatic hyperplasia; BSA, bovine serum albumin; CCK-8, cell counting kit-8; cDNA, complementary DNA; ceRNAs, competing endogenous RNAs; DAB, diaminobenzidine; DMEM, Dulbecco's modified Eagle's medium; DTT, dithiothreitol; ECL, enhanced chemiluminescence; EDTA, ethylene diamine tetraacetic acid; FBS, fetal bovine serum; GEO, Gene Expression Omnibus; IgG, immunoglobulin G; ISUP, International Society of Urological Pathology; lncRNAs, long non-coding RNAs;; miRNAs/miRs, microRNAs; MMP2, matrix metalloproteinase 2; mut, mutant; NC, negative control; NSCLC, non-small cell lung cancer; OD, optical density; Opti-MEM, Opti-minimum essential medium; PBS, phosphate buffered saline; PCA3, prostate cancer antigen 3; PCAT1, prostate cancer associated ncRNA transcript 1; PCGEM1, prostate cancer gene expression marker 1; PEI, polyethylenimine; PRR11, proline-rich protein 11; RAID, redundant arrays of inexpensive disks; RIP, RNA-binding protein immunoprecipitation; RIPA, radioimmunoprecipitation assay; RPMI, Roswell Park Memorial Institute; RT-qPCR, Reverse transcription quantitative polymerase chain reaction; siRNA, small interfering RNA; SP, streptavidin-perosidase; SPF, specific pathogen-free; SPSS, Statistical Product and Service Solutions; wt, wild type. 2017; Li et al, 2018). Furthermore, accumulating evidence has suggested that miRNAs play a crucial role in regulating tumor development (Ling et al, 2013;Rupaimoole and Slack, 2017).…”